Showing results (1451-1460 of 10,441) with videos related to
Sort By:
Pageof 1,045
AIDS (London, England)|November 20, 2014
Estimating HIV incidence from case-report data: method and an application in ColombiaJuan Fernando Vesga, Anne Cori, Ard van Sighem, et al.AIDS (London, England)|April 19, 2000
Progressive specific immune attrition after primary, secondary and tertiary immunizations with bacteriophage phi X174 in asymptomatic HIV-1 infected patientsA Rubinstein, Y Mizrachi, L Bernstein, et al.AIDS (London, England)|April 19, 2000
Comparison of clinical features, CD4 and CD8 responses among patients with acute HIV-1 infection from Geneva, Seattle and SydneyP Vanhems, J Hughes, A C Collier, et al.AIDS (London, England)|April 19, 2000
Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNAS Cu-Uvin, A M Caliendo, S Reinert, et al.AIDS (London, England)|April 19, 2000
Allelic frequencies of host genetic variants influencing susceptibility to HIV-1 infection and disease in South African populationsC Williamson, S A Loubser, B Brice, et al.AIDS (London, England)|February 24, 2001
Effect of computer-assisted self-interviews on reporting of sexual HIV risk behaviours in a general population sample: a methodological experimentA M Johnson, A J Copas, B Erens, et al.AIDS (London, England)|February 24, 2001
Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapyS Sonza, H P Mutimer, R Oelrichs, et al.AIDS (London, England)|February 24, 2001
Bacteremia due to Mycobacterium tuberculosis or M. bovis, Bacille Calmette-Guérin (BCG) among HIV- positive children and adults in ZambiaR D Waddell, K Lishimpi, C F von Reyn, et al.AIDS (London, England)|September 13, 2000
Protease sequences from HIV-1 group M subtypes A-H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide. HIV Variant Working GroupD Pieniazek, M Rayfield, D J Hu, et al.AIDS (London, England)|September 13, 2000
Semi-allogeneic cell hybrids stimulate HIV-1 envelope-specific cytotoxic T lymphocytesE Grene, D A Newton, E A Brown, et al.Pageof 1,045